The management of hospitalized COVID‐19 patients depends largely on controlling the intensified inflammatory response known as the cytokine storm. Candidate inflammatory cytokines can serve as new biomarkers for the management… Click to show full abstract
The management of hospitalized COVID‐19 patients depends largely on controlling the intensified inflammatory response known as the cytokine storm. Candidate inflammatory cytokines can serve as new biomarkers for the management of hospitalized COVID‐19 patients.
               
Click one of the above tabs to view related content.